0
Phathom Pharmaceuticals, Inc. Banner Image

Phathom Pharmaceuticals, Inc. has reached its limit for free report views

Work for Phathom Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Phathom Pharmaceuticals, Inc.

  • Ticker PHAT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Phathom Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Florham Park, New Jersey
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders.
Phathom Pharmaceuticals, Inc.

Most Recent Annual Report

Phathom Pharmaceuticals, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Phathom Pharmaceuticals, Inc. has reached its limit for free report views.